Surgical
treatment of trigeminal neuralgia (tic doloureux)
and glossopharyngeal neuralgia and hemifacial spasm
(tic convulsif) including microvascular decompression
and differential thermal rhizotomy or stereotactic
radiofrequency thermal lesioning.
The Purpose of this Center is to provide a complete
range of services for the diagnosis, treatment and
rehabilitation of patients with Trigeminal neuralgia
and Hemifacial Spasm. Patients may be referred for
consultation only, care in partnership with referring
physician, or complete management.
Articles: |
Wilkinson HA, Troup EC
and Chalpin JP: Broad Spectrum Approach
to Trigeminal Neuralgia Therapy. In Raj
P, Erdine S and Niv D, Eds.: Management
of Pain: A World Perspective II. Bologna,
Italy, Monduzzi Press, 1:259-261, 1996.
Wilkinson HA: Trigeminal Nerve Peripheral
Branch Phenol/glycerol Injections for Tic
Douloureaux. J. Neurosurg., 90:828-832,
1999.
|
- Neurosurgeons specializing in the treatment
of trigeminal neuralgia
and glossopharyngeal neuralgia and
informationabout the treatment of these
diseases at MGH/Harvard
- Neurosurgeons specializing in the treatment
of hemifacial
spasm and information about the treatment
of these diseases at MGH/Harvard
|
Neurosurgical treatment
of trigeminal neuralgia (tic doloureux) and glossopharyngeal
neuralgia.
Operations available include microvascular
decompression and differential
thermal rhizotomy or stereotactic radiofrequency
thermal lesioning, (which was developed
at MGH ):
Neurosurgical treatment
of hemifacial spasm (tic convulsif). Treatments
available include microvascular
decompression and botulinum toxin injection:
TRIGEMINAL NERVE BRANCH INJECTION
What is it? A procedure done in the doctor's
office that involves inserting a needle into a
small sensory (pain transmitting) branch of the
trigeminal nerve in a patient's face.
Why is it done? This is done partly
as an aid in diagnosing a patient's facial pain
problem, but chiefly in an effort to relieve
severe facial pain or trigeminal neuralgia.
Injecting one of these nerve branches with local
anesthetic should produce an area of reduced
feeling or numbness from the skin surface or
inside the mouth. If this relieves the major
portion of the patient's pain, this implies
that the nerve branch injected is likely to
be a major or important contributor to the patient's
pain. Injecting a destructive chemical (phenol,
used by the ancient Egyptians to make mummies)
usually interrupts functioning of the nerve
branch for six months to a year, occasionally
permanently, and can provide gratifying relief
of face pain. Most patients will obtain many
months of pain reduction from a single injection,
and a few will obtain permanent relief. Unfortunately
some patients will be disappointed by not obtaining
a useful degree of relief. If there is only
partial relief or if the relief fades, the procedure
can be repeated.
How is it done? The patient is not given
pre-medication or sedatives (which would interfere
with the patient being alert enough to accurately
assess the amount of pain relief achieved or
to go home safely). Injections are done with
the patient lying on his or her back. The skin
over the area to be injected is cleansed with
an antiseptic, then a local anesthetic (usually
Xylocaine) is injected into the skin and along
the proposed trajectory of the needle. The trigeminal
nerve is so named because it has three branches.
One exits below the eyebrow, one from the middle
to the cheek and one passes behind the angle
of the jaw. Where the needle is placed will
be determined by the location of the patient's
most severe pain. A local anesthetic is injected
around the nerve branch and the patient is asked
to observe whether he or she develops numbness
and any reduction in the ongoing and troublesome
pain. A small amount of phenol is injected before
the needle is withdrawn. A Band-Aid is applied
and the patient is assessed to be certain that
he or she feels well enough to be taken home
by a relative or friend.
Harold Wilkinson, M.D.
Hemifacial spasm/facial nerve links
References on Trigeminal
Neuralgia and Hemifacial Spasm
- The
Mount Sinai Journal of Medicine Percutaneous
Stereotactic Radiofrequency Thermal Rhizotomy
for the Treatment of Trigeminal Neuralgia Ernest
S. Mathews, M.D., and Steven J. Scrivani, D.D.S.,
M.D., D.M.Sc.
Abstract - Full
Text (pdf)
- Barker FG,
Jannetta PJ, Bissonette DJ, Larkins MV, Jho
HD. Long term outcome after microvascular decompression
for trigeminal neuralgia. New England Journal
of Medicine 334:1077-83, 1996.
- Barker FG,
Jannetta PJ, Babu RP, Pomonis S, Bissonette
DJ, Jho HD. Long term outcome after operation
for trigeminal neuralgia in patients with posterior
fossa tumors. Journal of Neurosurg, 84:818-825,
1996.
- Barker FG,
Jannetta PJ, Bissonette DJ, Shields PT, Larkins
MV, Jho HD. Microvascular decompression for
hemifacial spasm. Journal of Neurosurgery
82:201-10, 1995.
- Scrivani S, Mathews
ES, Keith D, Slawsby E. Percutaneous Differential
Radiofrequency Thermal Rhizotomy for the Treatment
of Trigeminal Neuralgia. Journal of Orofacial
Pain 1995. Vol 9, No 1.
|
Local
Emergency
Neurosurgical Hotline
617-277-2381
National
and
International Referrals
Neurosurgery @ MGH
617-726-8581
Neurosurgical
Spine
Referral Line
617-726-8668 |
|